Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05267873 · ClinicalTrials.gov registry record
Combining Data Sources to Identify Effect Moderation for Personalized Mental Health
A clinical trial, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- 9,586
- Enrollment target
NCT05267873 is a clinical trial that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 9,586 participants.
The verdict
NCT05267873 has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- 9,586 participants
- Enrollment target
Study Summary
This work will extend and apply methods for modeling heterogeneous treatment effects when multiple studies are available, with a particular focus on the complexities in mental health research. The methods will be illustrated in examples estimating the effects of medical treatments for major depressive disorder (duloxetine and vortioxetine) using 4 randomized controlled trials (available in the Vivli trials resource) and non-experimental data from the Duke University Health System electronic health record and the Johns Hopkins Health System electronic health record systems.
Interventions
- DRUG Duloxetine, Vortioxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,586 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2024-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05267873
The ClinicalTrials.gov registry entry for NCT05267873 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,586 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Duloxetine, Vortioxetine is the first listed.
NCT05267873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05267873 about?
NCT05267873 is a clinical study titled "Combining Data Sources to Identify Effect Moderation for Personalized Mental Health". This work will extend and apply methods for modeling heterogeneous treatment effects when multiple studies are available, with a particular focus on the complexities in mental health research. The methods will be illustrated in examples estimating the effects of medical treatments for major depressi...
What is the current status of trial NCT05267873?
This trial is currently completed. The enrollment target is 9,586 participants. The study started on 2015-01-01. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT05267873?
The interventions under investigation include: Duloxetine, Vortioxetine (DRUG).
Who is sponsoring clinical trial NCT05267873?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.